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Abstract
Background: Cardiovascular disease (CVD) remains a major cause of morbidity and a leading contributor to
mortality worldwide. Over the next 2 decades, it is projected that there will be a rise in CVD mortality rates in the
developing countries, linked to demographic changes and progressive urbanization. Nigeria has witnessed
tremendous socio-economic changes and rural-urban migration which have led to the emergence of non-
communicable diseases. We set out to determine the prevalence of modifiable CVD risk factors among apparently
healthy adult Nigerians. This is a descriptive cross-sectional study carried out at Katsina, northwestern Nigeria from
March to May 2006. Subjects for the study were recruited consecutively from local residents, hospital staff and
relations of in-patients of the Federal Medical Centre, Katsina using convenience sampling. Socio-demographic
information, anthropometric measurements and blood pressure were obtained from the subjects in a standardized
manner. Venous samples were collected for necessary investigations and analyzed at the hospital central
laboratory.
Findings: Three hundred subjects (129 males and 171 females) with a mean age of 37.6 ± 10.6 (range 18-75) years
were studied. Prevalence of the modifiable cardiovascular risk factors screened for were as follows: generalized
obesity 21.3% (males 10.9%, females 29.2%, p < 0.05), truncal obesity 43.7% (males 12.4%, females 67.3%, p < 0.05),
hypertension 25.7% (males 27.9, females 24%, p > 0.05), type 2 diabetes mellitus 5.3% (males 5.4%, females 5.3%, p
> 0.05), hypercholesterolaemia 28.3% (males 23.3%, females 32.2%, p < 0.05), elevated LDL-cholesterol 25.7% (males
28%, females 24%, p > 0.05), low HDL-cholesterol 59.3% (males 51.9%, females 65%, p < 0.05),
hypertriglyceridaemia 15% (males 16.3%, females 14%, p > 0.05) and metabolic syndrome 22% (males 10.9%,
females 30.4%, p < 0.05).
Conclusions: We found high prevalence of CVD risk factors among apparently healthy adult Nigerians. In order to
reduce this high prevalence and prevent subsequent cardiovascular events, encouragement of a healthy lifestyle is
suggested.
Introduction
Cardiovascular disease (CVD) remains a major cause of
morbidity and a leading contributor to mortality world-
wide. The World Health Report 1999 estimates that in
1998, 78% of the burden of non-communicable diseases
(NCDs) and 85% of the CV burden arose from the low
and middle income countries. The CVD burden afflicts
both men and women, with CV deaths accounting for
34% of all deaths in women and 28% in men in 1998[1].
As the epidemics advance, the social gradient also
reverses with the poor becoming the most vulnerable
victims in both developed and developing countries [2].
The high burdens of CVD in the developing countries
are attributable to the increasing incidence of athero-
sclerotic diseases, perhaps due to urbanization and
higher risk factor levels (such as obesity, diabetes, dysli-
pidemia, hypertension), the relatively early age at which
they manifest, the large sizes of the population, and the
high proportion of individuals who are young adults or
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middle-aged in these countries[3]. For example, about
half of the deaths attributable to CVD in the developing
countries in 1990 occurred below the age of 70 years, in
contrast to about a quarter in the developed countries
[4]. Such a pattern of premature CVD mortality is likely
to haunt the developing countries even more in the
future. Between 1990 and 2020, the increase in coronary
heart disease (CHD) mortality (120% in women and
137% in men) in the developing countries is expected to
be much greater than among developed countries (29%
and 48% in women and men respectively)[4].
It is estimated that the elderly population will increase
globally (over 80% during the next 25 years), with a
large share of this rise in the developing world because
of expanding populations. Increased longevity due to
improved social and economic conditions associated
with lifestyle changes in the direction of a rich diet and
sedentary habits, is one of the main contributors to the
incremental trend in CVD in the last century[5]. Nigeria
has witnessed tremendous socio-economic changes and
rural-urban migration which have led to emergence of
non-communicable diseases including ischaemic heart
disease[6]. The development of CVD is promoted by
major risk factors - dyslipidemia, hypertension, diabetes
(DM) and smoking. These risk factors are independently
associated with CVD risk and are common among
adults both in the developed and developing countries.
The identification of these major risk factors and the
implementation of control strategies (e.g. community
education and target of high risk individuals) have con-
tributed to the fall in CVD mortality rates observed in
industrialized nations[7]. The non-communicable dis-
ease (NCD) survey done in Nigeria about 15 years ago
sought to determine the prevalence of major risk factors
in the country [8]. With socio-economic changes, rural-
urban migration and changes in the definition of the
various risk factors, it is likely that the prevalence of
these risk factors is increasing. Furthermore, control of
infectious, parasitic, and nutritional diseases allows most
of the population to reach the ages in which CVD mani-
fests itself. This is the concept of “epidemiologic transi-
tion” on which the basis for a prediction of a global
CVD epidemic lies[9]. We therefore set out to provide
descriptive information regarding the risk factors for
CVD in a sample of apparently healthy adult Nigerians,
describe how these risk factors relate to one another
and also establish a baseline and make appropriate
recommendations.
Methods
This was a descriptive cross-sectional study carried out
in Katsina city, in the north western region of Nigeria
between March and May, 2006. The city, which has a
total population of 459,022 based on 2006 national
census figures with a male to female ratio of 1:1.05, is
composed majorly of Hausa and Fulani tribes while
other Nigerian tribes are found in minority.
Using convenience sampling method, subjects were
consecutively recruited after obtaining a written
informed consent. The recruited respondents were
members of the public, hospital staff and relations of
inpatients who were requested to come for a free
screening after a health education on the need for pre-
vention of CVD risk factors was given to them by the
investigators. Screening was conducted at the Federal
Medical Centre, Katsina which is a tertiary hospital that
serves as a referral centre for all primary and secondary
healthcare facilities in Katsina state.
Subjects were considered apparently healthy if they
were asymtomatic, had no physical disability and
believed they were in a good state of health. The study
protocol was approved by the research and ethics com-
mittee of the hospital. In a standardized manner, infor-
mation was obtained on relevant sociodemographic
characteristics like age, sex, current history of alcohol or
tobacco use, hypertension and diabetes mellitus with the
aid of an interviewer-administered semi-structured
questionnaire.
Anthropometric and blood pressure measurements
All anthropometric measurements were made by 2
trained research assistants. Weight was taken with light
clothing on with the aid of a weighing scale with the
weights measured to the nearest 100 g, while for mea-
surement of height, a stadiometer was used[10]. Body
mass index (BMI) was then calculated from weight (in
kilogrammes) divided by a square of the height (in
metres). Blood pressure (BP) was measured in the left
arm in the sitting position with the aid of a mercury
sphygmomanometer using the auscultation method. The
systolic blood pressure was recorded at phase I Korotk-
off sounds while the diastolic blood pressure was
recorded at phase V Korotkoff sounds. All measure-
ments were taken twice and the average of the 2 read-
ings was taken as final.
Biochemical analysis
After 10-12 hours of overnight fast, venous samples
were obtained from the subjects.
The serum was immediately separated by centrifuga-
tion, and the concentration of triglycerides (TG), total
cholesterol (TC) and its fractions [low-density lipopro-
teins (LDL-C) and high-density lipoproteins (HDL-C)]
were ascertained. Fasting plasma glucose and serum uric
acid were also measured.
Definition of Risk Factors
Hypertension was taken as a positive history, use of
antihypertensive drugs or persistently elevated BP
(>140/90 mmHg) while DM was regarded as a positive
history, use of hypoglycaemic agents or a fasting plasma
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glucose > 126 mg/dl (7.0 mmol/L). Total cholesterol was
considered to be high if it was >200 mg/dl. LDLc was
considered to be raised if it was >130 mg/dl, triglycer-
ides was considered to be high if it was > 150 mg/dl
and HDLc was considered to be low if it was < 40 mg/
dl and <50 mg/dl in men and women respectively. Obe-
sity was defined with the BMI using the WHO classifi-
cation[11]. Metabolic syndrome was defined using the
national cholesterol education programme (NCEP) adult
treatment panel (ATP) III criteria[12]. According to this
criteria a subject has metabolic syndrome if he or she
has three or more of the following: waist circumference
>102 cm in men and >88 cm in women; triglyceride
levels ≥ 150 mg/dl; HDL cholesterol concentration <40
mg/dl in men and <50 mg/dl in women; blood pressure
≥ 130/85 mmHg; and fasting plasma glucose value ≥110
mg/dl. Atherogenic index (AI) was calculated as the
ratio of HDLc to TC. High risk was defined as HDLc/
TC < 0.18, while average and low risk was 0.18 to 0.40
and >0.40 respectively, according to the European
Atherosclerosis society guidelines[13].
Statistical Analysis
Data analysis was done using the Statistical Package for
the Social Sciences (SPSS), version 13.0. Analysis of con-
tinuous variables was carried out using the procedures
of descriptive statistics and later, to identify any differ-
ences we used Student’s “t” test. Categorical variables
were analyzed using contingency tables involving chi-
square (X2) tests to identify statistical differences
between the genders. In order to determine the correla-
tion of each of the clinical and laboratory characteristics
of the respondents with atherogenic index, Pearson’s
correlation coefficient was done. Statistical significance
was set at the conventional p < 0.05.
Results
A total of 321 subjects turned out for the study of
whom 300 had complete data for analysis. There were
129 males and 171 females (ratio 1:1.3); and their ages
ranged from 18-75 (mean 37.6 ± 10.6) years. Figure 1
shows the age and sex distribution of the study subjects.
Most (34.3%) of the study subjects were in the 35-44
year age group. There were more females than males
across all age groups. The males were aged 18-58 years
(mean 38.0 ± 9.7) while females were aged 18-75 (mean
37.2 ± 11.2), p > 0.05.
There were 48 known hypertensives subjects of whom
40 were on treatment. Nineteen (47.5%) of those on
treatment had their BP under control. Twenty nine
(9.7%) of the subjects were newly discovered to have
hypertension. This together with the known hyperten-
sives makes the hypertension prevalence among the
study subjects to be 25.7% (77/300). Ten of the subjects
were cases of type 2 DM, out of whom 8 were on
treatment and 5 had good glycaemic control. Six sub-
jects were newly found have type 2 DM altogether mak-
ing type 2 DM to be present in 16 (5.3%).
Sixty four (21.3%) of the subjects were obese (BMI >
30 kg/m2) while 96 (32%) were overweight (BMI 25-29.9
kg/m2). Across all grades of obesity and the overweight
class, females were significantly more affected than
males (p < 0.05). Sixteen (12.4%) males and 115 (64.2%)
females had increased waist circumference more than
102 cm and 88 cm respectively. Cigarette smoking was
found in 14 (4.7%) of whom 11 (79%) were males. Alco-
hol consumption was generally low and was present in
17 (5.7%) subjects, 14 (82%) of whom are males. The
means of clinical and laboratory characteristics of the
subjects are shown in Table 1.
Table 2 shows the overall and gender frequencies of
the modifiable cardiovascular risk factors. Eighty five
(28.3%) had raised total cholesterol, 77 (25.7%) had
raised LDLc and 67 (52%) male and 111 (65%) females
had low HDLc. Trigycerides was high in 45 (15%) of the
subjects. Thirty eight (29.5%) males and 39 (22.8%)
females had CHD risk ratio in the high risk category
(HDLc/TC < 0.18). Metabolic syndrome was present in
66 (22%) of the subjects, 52 (30.4%) of whom were
females (p < 0.001).
Table 3 shows that CHD risk ratio correlated nega-
tively with TC (r = -0.3, p < 0.05), LDLc (r = -0.5, p <
0.05) and WC (r = -0.2, p < 0.05) and correlated posi-
tively with HDLc (r = 0.9, p < 0.05).
Discussion
Developing countries face the double menace of preva-
lent infectious diseases and increasing CVD with pro-
jected epidemic proportions in the near future. CVD has
become the number-one cause of death in the develop-
ing world, causing twice as many deaths as HIV,
malaria, and tuberculosis combined[14]. This epidemic
has the potential to place a large social and economic
burden on developing countries, where CVD tends to
strike those in their prime of life[15]. In developing
countries, the increase in CVD burden is largely the
result of an increase in the prevalence of risk factors
and a relative lack of access to various interventions
used to achieve successes in developed countries.
Many earlier studies in Nigeria sought to describe pre-
valence of risk factors for CVD in specific populations
like those with hypertension, diabetes and the aged
[16-18]. The present study, in addition to providing
descriptive information on CVD risk factors in a sample
of apparently healthy adult Nigerians, has also tried to
establish to what extent these risk factors relate to one
another.
The NCD survey of CV risk factors in Nigeria con-
ducted 15 years earlier reported the age-adjusted
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prevalence of hypertension to be 11.2%, using a qualify-
ing BP level of 160/95 mmHg[8]. Using the same quali-
fying BP level, other workers found the prevalence of
hypertension to be 12.4% in south western Nigeria [19].
Extrapolations from the NCD data and from other stu-
dies suggest an urban prevalence rate of around 20%
using the current cut-off point of 140/90 mmHg [20,21].
In a survey of cardiovascular risk factors in middle aged
Nigerians aged 50-54 years, hypertension was found in
25% of males and 16.4% of females [18]. The prevalence
of hypertension found in this study is comparable to
that found by these other workers in the recent past.
This shows that the prevalence of hypertension in
Nigeria has increased when compared with the findings
from the NCD survey 15 years ago.
The prevalence of type 2 DM was 5.3%, which is
higher than the 2.2%-2.8% found by other workers in
the country[8,18,22]. Rotimi and colleagues reported the
age adjusted prevalence of type 2 DM to be 1%, 12%
and 13% among Nigerians, Jamaicans and US blacks
respectively[23]. There have been comments and projec-
tions about the rising incidence of diabetes worldwide
[24]. It is important to note that in the present study,
there is a positive correlation between the measures of
obesity (BMI and waist circumference) and fasting
plasma glucose. It is possible that the high prevalence of
Figure 1 Age and sex distribution of respondents.
Table 1 Means of Clinical and Laboratory Characteristics of the subjects
Variable Overall (n = 300) Male (n = 129) Female (n = 171) p value
Age, years 37.6 ± 10.6 38.0 ± 9.7 37.2 ± 11.2 0.54
BMI, kg/m2 26.0 ± 5.8 24.1 ± 4.0 27.5 ± 6.5 < 0.001
WC, cm 91.1 ± 14.5 87.6 ± 10.9 93.7 ± 16.2 < 0.001
Systolic BP, mmHg 120.4 ± 21.1 117.9 ± 18.9 122.3 ± 22.4 0.07
Diastolic BP, mmHg 78.9 ± 13.5 77.4 ± 11.8 80.1 ± 14.6 0.10
FPG, mg/dl 82.9 ± 20.9 82.9 ± 15.4 82.9 ± 24.2 0.99
TC, mg/dl 178.2 ± 38.0 172.8 ± 35.6 182.3 ± 39.4 0.03
HDL cholesterol, mg/dl 45.3 ± 21.7 40.1 ± 14.6 49.2 ± 25.1 < 0.001
LDL cholesterol, mg/dl 106.8 ± 38.9 105.7 ± 38.1 107.7 ± 39.5 0.66
Triglyceride, mg/dl 101.3 ± 49.1 104.4 ± 46.2 99.1 ± 51.2 0.36
HDLc/TC 0.25 ± 0.12 0.24 ± 0.11 0.27 ± 0.13 0.02
Values are Mean ± SD. BMI = body mass index, WC = waist circumference, BP = blood pressure, FPG = fasting plasma glucose, TC = fasting total cholesterol, HDL
= high density lipoprotein, LDL = low density lipoprotein
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DM in this study is a reflection of high prevalence of
both generalized and truncal obesities since the latter is
an indirect measure of insulin resistance which is the
hallmark of type 2 DM. However, although BMI and
waist circumference are significantly higher in our
female subjects, the reason for lack of difference in the
gender prevalence of DM is not apparent.
As compared to men, women had higher BMI (27.5
versus 24.1 kg/m2, p < 0.05). This agrees with findings
of other studies in the Nigeria[18] and elsewhere in
Africa[25]. Waist circumference (WC) is an index of
truncal obesity and when increased is unfavourably asso-
ciated with cardiovascular disease risk. The WC showed
women were more obese than men in agreement with
other studies[18,25]. The high proportion of obese sub-
jects especially among women is likely due to the fact
that obesity is still “fashionable” in Nigeria, especially
among women as it is thought to depict affluence[26].
In addition, traditional African culture does not encou-
rage physical exercise especially among women. Most of
the subjects had sedentary lifestyles which encourage
weight gain.
There is a high prevalence of dyslipidaemia in our
subjects with the most common in both sexes being low
HDL-cholesterol. In agreement with the results of other
studies[18,25], the females presented a higher
proportion of those with significantly higher concentra-
tions of TC and reduced levels of HDLc fraction.
Metabolic syndrome was present in 22% which is
comparable to the 21.8% reported in the USA[27]; how-
ever, this prevalence is lower compared to the findings
of Ker et al[28] in South Africa among corporate execu-
tives using the same criteria like we used in our study.
The difference could possibly be as a result of the fact
that their study was among corporate executives who
were already at increased risk for metabolic syndrome
because of the sedentary nature of their job. The higher
frequency of metabolic syndrome among our female
subjects is also comparable to the findings of Gupta et
al[29] (47.8% vs 36.2%) and Azizi et al[30] (42% vs 24%).
Almost 1 out of every 4 individuals screened had
atherogenic index below 0.18 which implies that they
are at high risk of CHD and this did not show any gen-
der disparity. This finding is of great concern because
CHD was thought to be rare in Nigeria. The high preva-
lence of those with atherogenic index in the high risk
category is expected because of the high prevalence of
dyslipidaemia in the study subjects. Nigeria is witnessing
both epidemiologic and demographic transitions and the
high rate of CVD risk factors in our subjects should
serve as an eye opener to the health workers and policy
makers on the need for a strategic plan to prevent this
from getting to an epidemic dimension.
Table 2 Frequency of cardiovascular disease risk factors, metabolic syndrome and artherogenic index.
CV risk factor Overall, n (%) Male, n (%) Female, n (%) p value
Hypertension 77(25.7) 36(27.9) 41(24.0) 0.23
DM 16 (5.3) 7(5.4) 9(5.3) 0.56
BMI >30 kg/m2 64 (21.3) 14 (10.9) 50(29.2) < 0.001
Truncal obesity 131(43.7) 16(12.4) 115(67.3) < 0.001
Hypercholesterolaemia 85(28.3) 30(23.3) 55(32.2) < 0.05
Raised LDLc 77(25.7) 36(28.0) 41(24.0) 0.59
Low HDLc 178(59.3) 67 (51.9) 111(65.0) < 0.001
Hypertriglyceridaemia 45(15.0) 21(16.3) 24 (14.0) 0.59
Cigarette smoking 14(4.7) 11(8.5) 3 (1.8) < 0.001
Metabolic syndrome 66(22.0) 14(10.9) 52(30.4) < 0.001
HDLc/TC (< 0.18) 77(25.7) 38(29.5) 39(22.8) 0.86
DM; Diabetes Mellitus, BMI; body mass index, LDLc; low density lipoprotein cholesterol, HDLc; high density lipoprotein cholesterol, TC; total cholesterol, HDLc/TC;
atherogenic index.
Table 3 Clinical and laboratory characteristics with significant correlation with artherogenic index
Cardiovascular risk factor Pearson’s correlation coefficient (r) p value
Waist circumference -0.20 0.001
Weight -0.16 0.005
Total cholesterol -0.30 < 0.001
HDLc 0.87 < 0.001
LDLc -0.50 < 0.001
Metabolic syndrome -0.20 0.001
Note: Artherogenic index = HDLc/TC
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We acknowledge that our study is limited in a number
of ways. Firstly the sample size is small for this kind of
study and this could have increased the probability of
type 2 error. Secondly, the non-probability sampling
technique used could have possibly increased the risk of
bias. As such, the results cannot be generalized to the
entire population. We however feel that because our
respondents were recruited consecutively without any
selection, the chances of bias was reduced. Additionally,
as we did not screen for other established CVD risk fac-
tors like microalbuminuria, homocysteinaemia and C
reactive protein, the relative contributions of each of
these to the burden of cardiovascular disease in our
environment could not be determined. The findings of
this study can serve as a template for a proper commu-
nity-based study on the same subject in the country,
especially in view of the high prevalence of the CVD
risk factors screened for.
Conclusions and Recommendations
This study has shown that there is a high prevalence of
cardiovascular risk factors among our study population,
with females having significantly higher prevalence rates
compared to males. Also, as a result of this high preva-
lence of CVD risk factors, almost 1 out of every 4
apparently healthy individuals in Nigeria could be at
high risk of CHD. It is therefore important for us to
develop a proactive approach to managing the looming
epidemic of cardiovascular diseases. We also need to
promote lifestyle-related disease control and prevention
programmes which include intake of healthy diet, regu-
lar aerobic exercises and decreased tobacco and alcohol
use.
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